193 related articles for article (PubMed ID: 17963850)
1. Methylphenidate and cocaine: the same effects on gene regulation?
Yano M; Steiner H
Trends Pharmacol Sci; 2007 Nov; 28(11):588-96. PubMed ID: 17963850
[TBL] [Abstract][Full Text] [Related]
2. Methylphenidate (Ritalin) induces Homer 1a and zif 268 expression in specific corticostriatal circuits.
Yano M; Steiner H
Neuroscience; 2005; 132(3):855-65. PubMed ID: 15837145
[TBL] [Abstract][Full Text] [Related]
3. Repeated methylphenidate treatment in adolescent rats alters gene regulation in the striatum.
Brandon CL; Steiner H
Eur J Neurosci; 2003 Sep; 18(6):1584-92. PubMed ID: 14511337
[TBL] [Abstract][Full Text] [Related]
4. Neuronal development genes are key elements mediating the reinforcing effects of methamphetamine, amphetamine, and methylphenidate.
Dela Peña I; Jeon SJ; Lee E; Ryu JH; Shin CY; Noh M; Cheong JH
Psychopharmacology (Berl); 2013 Dec; 230(3):399-413. PubMed ID: 23783774
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of methylphenidate-induced gene expression in the striatum by local blockade of D1 dopamine receptors: interhemispheric effects.
Yano M; Beverley JA; Steiner H
Neuroscience; 2006 Jun; 140(2):699-709. PubMed ID: 16549270
[TBL] [Abstract][Full Text] [Related]
6. The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities.
Faraone SV
Neurosci Biobehav Rev; 2018 Apr; 87():255-270. PubMed ID: 29428394
[TBL] [Abstract][Full Text] [Related]
7. Is the treatment with psychostimulants in children and adolescents with attention deficit hyperactivity disorder harmful for the dopaminergic system?
Gerlach M; Grünblatt E; Lange KW
Atten Defic Hyperact Disord; 2013 Jun; 5(2):71-81. PubMed ID: 23605387
[TBL] [Abstract][Full Text] [Related]
8. Performance enhancing, non-prescription use of Ritalin: a comparison with amphetamines and cocaine.
Svetlov SI; Kobeissy FH; Gold MS
J Addict Dis; 2007; 26(4):1-6. PubMed ID: 18032226
[TBL] [Abstract][Full Text] [Related]
9. Selective serotonin re-uptake inhibitors potentiate gene blunting induced by repeated methylphenidate treatment: Zif268 versus Homer1a.
Van Waes V; Vandrevala M; Beverley J; Steiner H
Addict Biol; 2014 Nov; 19(6):986-95. PubMed ID: 23763573
[TBL] [Abstract][Full Text] [Related]
10. Dysregulation of gene induction in corticostriatal circuits after repeated methylphenidate treatment in adolescent rats: differential effects on zif 268 and homer 1a.
Cotterly L; Beverley JA; Yano M; Steiner H
Eur J Neurosci; 2007 Jun; 25(12):3617-28. PubMed ID: 17610581
[TBL] [Abstract][Full Text] [Related]
11. Social isolation rearing increases dopamine uptake and psychostimulant potency in the striatum.
Yorgason JT; Calipari ES; Ferris MJ; Karkhanis AN; Fordahl SC; Weiner JL; Jones SR
Neuropharmacology; 2016 Feb; 101():471-9. PubMed ID: 26525189
[TBL] [Abstract][Full Text] [Related]
12. Fluoxetine potentiation of methylphenidate-induced neuropeptide expression in the striatum occurs selectively in direct pathway (striatonigral) neurons.
Van Waes V; Carr B; Beverley JA; Steiner H
J Neurochem; 2012 Sep; 122(5):1054-64. PubMed ID: 22738672
[TBL] [Abstract][Full Text] [Related]
13. Addiction-related gene regulation: risks of exposure to cognitive enhancers vs. other psychostimulants.
Steiner H; Van Waes V
Prog Neurobiol; 2013 Jan; 100():60-80. PubMed ID: 23085425
[TBL] [Abstract][Full Text] [Related]
14. Adolescent exposure to cocaine, amphetamine, and methylphenidate cross-sensitizes adults to methamphetamine with drug- and sex-specific effects.
Shanks RA; Ross JM; Doyle HH; Helton AK; Picou BN; Schulz J; Tavares C; Bryant S; Dawson BL; Lloyd SA
Behav Brain Res; 2015 Mar; 281():116-24. PubMed ID: 25496784
[TBL] [Abstract][Full Text] [Related]
15. Paradoxical striatal cellular signaling responses to psychostimulants in hyperactive mice.
Beaulieu JM; Sotnikova TD; Gainetdinov RR; Caron MG
J Biol Chem; 2006 Oct; 281(43):32072-80. PubMed ID: 16954211
[TBL] [Abstract][Full Text] [Related]
16. The neuropharmacology of ADHD drugs in vivo: insights on efficacy and safety.
Heal DJ; Cheetham SC; Smith SL
Neuropharmacology; 2009 Dec; 57(7-8):608-18. PubMed ID: 19761781
[TBL] [Abstract][Full Text] [Related]
17. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
[TBL] [Abstract][Full Text] [Related]
18. Dynamic changes in sensitivity occur during the acute response to cocaine and methylphenidate.
Kuczenski R; Segal DS
Psychopharmacology (Berl); 1999 Nov; 147(1):96-103. PubMed ID: 10591874
[TBL] [Abstract][Full Text] [Related]
19. The Impact of Chronic Early Administration of Psychostimulants on Brain Expression of BDNF and Other Neuroplasticity-Relevant Proteins.
Simchon Tenenbaum Y; Weizman A; Rehavi M
J Mol Neurosci; 2015 Oct; 57(2):231-42. PubMed ID: 26152882
[TBL] [Abstract][Full Text] [Related]
20. Anti-hyperactivity medication: methylphenidate and amphetamine.
Seeman P; Madras BK
Mol Psychiatry; 1998 Sep; 3(5):386-96. PubMed ID: 9774771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
